![stock photo of hand over a heart](https://www.uc.edu/news/articles/2019/09/n20854781/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1567690975716.jpg)
Medscape: AFIRE encourages less antiplatelet use with novel oral anticoagulant for atrial fibrillation treatment
UC cardiologist weighs in on trial looking at therapies for heart patients
Medscape turned to the expertise of Richard Becker, MD, Director, UC Heart, Lung and Vascular Institute, when reporting the results of a randomized trial comparing an oral anticoagulation with an antiplatelet agent versus an oral anticoagulation alone in patients with both atrial fibrillation and stable coronary artery disease. Becker, also director of the UC Division of Cardiovascular Health and Disease in the College of Medicine and a UC Health cardiologist, authored a New England Journal of Medicine editorial on the results of the AFIRE trial.
Richard Becker, MD
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
Cincinnati researchers want to know if MRIs can work better
![WVXU logo](/content/dam/refresh/uc-news/news-icons/dark/wvxu.png)
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.
UC opens Blood Cancer Healing Center
![WLWT 5 logo](/content/dam/refresh/uc-news/news-icons/dark/wlwt-dark.png)
June 28, 2024
Media outlets including WLWT, Local 12, Spectrum News, the Cincinnati Enquirer and Cleveland.com highlighted the opening of the University of Cincinnati Cancer Center's Blood Cancer Healing Center.